Clinical Trial Update: Cosopt Versus Xalatan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Cosopt (dorzolamide/timolol) with Xalatan (latanoprost) in open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Cosopt (dorzolamide/timolol)
• Xalatan (latanoprost)

Snippet

Sponsor: Pharmaceutical Research Network | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED